Doisynoestrol
Doisynoestrol (brand names Fenocyclin, Surestrine, Surestryl; former developmental code name RS-2874), also known as fenocycline, as well as cis-bisdehydrodoisynolic acid 7-methyl ether (BDDA ME), is a synthetic nonsteroidal estrogen of the doisynolic acid group that is no longer marketed.[1][2] It is a methyl ether of bisdehydrodoisynolic acid.[1] Doisynoestrol was described in the literature in 1945.[1]
Clinical data | |
---|---|
Trade names | Fenocyclin, Surestrine, Surestryl |
Other names | Diosynestrol; Fenocycline; Fenocyclin; Phenocyclin; RS-2874; Dehydrofolliculinic acid; cis-Bisdehydrodoisynolic acid 7-methyl ether; BDDA ME; |
Routes of administration | By mouth |
Drug class | Nonsteroidal estrogen |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C19H22O3 |
Molar mass | 298.382 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
See also
References
- J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 465–. ISBN 978-1-4757-2085-3.
- Herbai, G. (1971). "SEPARATION OF GROWTH INHIBITING POTENCY FROM OESTROGENICITY IN DIFFERENT WEAK OESTROGENIC DRUGS OF VARIOUS CHEMICAL STRUCTURES". European Journal of Endocrinology. 68 (2): 249–263. doi:10.1530/acta.0.0680249. ISSN 0804-4643.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.